Clinical Trial Update: Fenretinide in Treating Patients With Recurrent Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fenretinide for recurrent malignant glioma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED